Picture supply: Getty Photographs
The FTSE 100’s lengthy lagged the mighty S&P 500. Over the previous decade, the US index powered forward, fuelled by surging tech valuations, whereas the UK’s flagship index remained caught below the burden of sluggish banks and oil giants.
However 2025’s delivered a shock. Up to now this 12 months, the Footsie’s returned over 7% — barely forward of the S&P 500’s roughly 6.5%. That’s a dramatic change in comparison with current years, and an indication that UK blue-chips are lastly holding their very own.
Dig slightly deeper, and it’s clear what’s driving this. A handful of FTSE shares have smashed expectations, outperforming virtually each main US firm.
Mexico-focused silver miner Fresnillo is up greater than 130%, engineering heavyweight Babcock’s surged 116%, and Rolls-Royce continues its astonishing multi-year run, gaining one other 73% in 2025 alone.
Of all corporations on the S&P 500, solely Palantir’s within the prime three, edging barely forward of Rolls this 12 months with 84%. In fifth place is NRG Vitality, up 65% 12 months to this point.
What’s driving the surge?
A lot of the expansion comes all the way down to particular tailwinds. Treasured metals are hovering amid international uncertainty, fuelling Fresnillo. Defence budgets are booming, propping up Babcock and Rolls. In the meantime, a recovering oil worth and resilient international demand have helped shore up many FTSE stalwarts.
However a few of these strikes could also be getting forward of themselves. Share costs that rocket on hopes alone can simply change into ‘development traps’, the place valuation disconnects from long-term fundamentals. That’s why I choose to maintain a rational outlook when markets go a bit loopy.
Robust earnings, cheap valuations and stable stability sheets typically matter extra in the long term than short-term worth jumps.
A extra cautious FTSE 100 choose
One inventory that’s performing extra ‘moderately’ proper now’s Beazley (LSE: BEZ). The specialist insurer has quietly delivered reasonable development this 12 months, up 8.8% — nothing flashy, however comfortably forward of the index’s historic averages.
Extra importantly, it’s supported by stable working traits. Earnings per share are rising at 9.9% 12 months on 12 months, with income up 7.8%. That’s feeding right into a wholesome web margin of 18% and a formidable return on equity (ROE) of 26.3%.
Valuation additionally appears to be like enticing. The shares commerce on a price-to-earnings (P/E) ratio of simply 6.67 and a price-to-book (P/B) a number of of 1.55, suggesting buyers aren’t paying over the percentages for this high quality development.
It’s not an enormous revenue play, however the dividend yield of two.8% is nicely lined by a payout ratio of simply 18.3%. Free money circulation is reassuring at £1.26bn, comfortably outstripping its £614m of debt. Plus, the dividend has been raised for 3 years working.
Dangers to look at
After all, insurance coverage generally is a unstable enterprise. Beazley faces publicity to large-catastrophe-linked losses, which may dent income in any given 12 months. It’s additionally susceptible to pricing cycles in speciality insurance coverage, which may swing from profitable to lean shortly if competitors intensifies.
However general, I feel it’s the form of stable British enterprise that’s value contemplating for sturdy reliability.
Whereas development shares fluctuate wildly, it’s these regular compounders — buying and selling on wise valuations — that usually ship one of the best returns over time. When constructing a diversified long-term portfolio, that’s precisely what buyers needs to be on the lookout for.
